Skip to main content

Advertisement

Log in

Natural history of vertically acquired HCV infection and associated autoimmune phenomena

  • Original Article
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

The natural history of vertically acquired HCV infection is ill defined. The aim of this study was to outline the natural course of vertical HCV infection in a cohort of untreated children, including rate of spontaneous viral clearance, frequency and features of HCV-related autoimmune disorders. Children with vertical HCV infection were prospectively followed from the first month of life with regular clinical and laboratory assessments. Statistical analysis was performed using Prism 5.0. Forty-five children (median age 12 years, interquartile range 6.9–15.5) were studied. Genotype 1 was predominant (53.3 %). Spontaneous viral clearance was achieved by 12 patients (26.7 %) and associated with genotype 3. Alanine-amino-transferase levels were increased in most children in the first 2 years of life with higher values in those who later cleared the infection. All children were asymptomatic for liver disease. Transient elastography (32 patients) showed mild or moderate fibrosis in nine and two cases, respectively. Non-organ-specific autoantibodies were detected in 24 children (53.3 %) independently of viremia; of these, one developed type-1 diabetes. Cryoglobulinemia was associated with genotype 1 infection and found in 15 subjects (33.3 %): two had low C4 levels and persistent proteinuria. Conclusions: Vertically acquired HCV infection may result in spontaneous clearance in up to 27 % of children. Resolution of infection is higher with genotype 3, usually occurs in preschool age and persists over time. Chronic infection is generally asymptomatic, although hepatomegaly and mild fibrosis may develop. Autoantibodies and cryoglobulins are frequent, whereas the associated clinical manifestations are rare.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

ALT:

Alanine-amino-transferase

AMA:

Antimitochondrial antibodies

ANA:

Antinuclear antibodies

CI:

Confidence interval

ELISA:

Enzyme-linked immunosorbent assay

HCV:

Hepatitis C virus

HIV:

Human immunodeficiency virus

IFN:

Interferon

L:

Litre

LKM-1:

Liver kidney microsomal type 1 antibodies

NA:

Not available

ND:

Not detected

NOSAs:

Non-organ-specific autoantibodies

PCR:

Polymerase chain reaction

RNA:

Ribonucleic acid

SMA:

Antismooth muscle antibodies

SVC:

Sustained viral clearance

U:

Unit

References

  1. Abdel-Hady M, Bunn SK, Sira J, Brown RM, Brundler MA, Davies P, Kelly DA (2011) Chronic hepatitis C in children — review of natural history at a National Centre. J Viral Hepat 18:e535–e540

    Google Scholar 

  2. Boccato S, Pistis R, Noventa F, Guido M, Benvegnù L, Alberti A (2006) Fibrosis progression in initially mild chronic hepatitis C. J Viral Hepat 13:297–302

    Article  CAS  PubMed  Google Scholar 

  3. Bortolotti F, Vajro P, Balli F, Giacchino R, Crivellaro C, Barbera C, Cataleta M, Muratori L, Pontisso P, Nebbia G, Zancan L, Bertolini A, Alberti A, Bianchi F (1996) Non-organ specific autoantibodies in children with chronic hepatitis C. J Hepatol 25:614–620

    Article  CAS  PubMed  Google Scholar 

  4. Bortolotti F, Verucchi G, Cammà C, Cabibbo G, Zancan L, Indolfi G, Giacchino R, Marcellini M, Marazzi MG, Barbera C, Maggiore G, Vajro P, Bartolacci S, Balli F, Maccabruni A, Guido M, Italian observatory for HCV infection and hepatitis C in children (2008) Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. Gastroenterology 134:1900–1907

    Article  PubMed  Google Scholar 

  5. Camarero C, Ramos N, Moreno A, Asensio A, Mateos ML, Roldan B (2008) Hepatitis C virus infection acquired in childhood. Eur J Pediatr 167:219–224

    Article  PubMed Central  PubMed  Google Scholar 

  6. Carreño V, Bartolomé J, Castillo I, Quiroga JA (2012) New perspectives in occult hepatitis C virus infection. World J Gastroenterol 18:2887–2894

    Article  PubMed Central  PubMed  Google Scholar 

  7. Cerutti F, Palomba E, Sacchetti C, Gay V, Versace A, Tovo PA (1999) Anti-HCV antibodies in a population of insulin-dependent diabetic children and adolescents. Diabetes Care 22:1587–1588

    Article  CAS  PubMed  Google Scholar 

  8. Conte D, Fraquelli M, Prati D, Colucci A, Minola E (2000) Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology 31:751–755

    Article  CAS  PubMed  Google Scholar 

  9. European Paediatric Hepatitis C Virus Network (2005) Three broad modalities in the natural history of vertically acquired hepatitis C virus infection. Clin Infect Dis 41:45–51

    Article  Google Scholar 

  10. Farmand S, Wirth S, Löffler H, Woltering T, Kenzel S, Lainka E, Henneke P (2012) Spontaneous clearance of hepatitis C virus in vertically infected children. Eur J Pediatr 171:253–258

    Article  PubMed  Google Scholar 

  11. Fitzpatrick E, Quaglia A, Vimalesvaran S, Basso MS, Dhawan A (2013) Transient elastography is a useful noninvasive tool for the evaluation of fibrosis in paediatric chronic liver disease. J Pediatr Gastroenterol Nutr 56:72–76

    Article  PubMed  Google Scholar 

  12. Gehring S, Kullmer U, Koeppelmann S, Gerner P, Wintermeyer P, Wirth S (2006) Prevalence of autoantibodies and the risk of autoimmune thyroid disease in children with chronic hepatitis C virus infection treated with interferon-alpha. World J Gastroenterol 12:5787–5792

    CAS  PubMed  Google Scholar 

  13. Goldschmidt I, Streckenbach C, Dingemann C, Pfister ED, di Nanni A, Zapf A, Baumann U (2013) Application and limitations of transient liver elastography in children. J Pediatr Gastroenterol Nutr 57:109–113

    Article  PubMed  Google Scholar 

  14. Gregorio GV, Pensati P, Iorio R, Vegnente A, Mieli-Vergani G, Vergani D (1998) Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection. Clin Exp Immunol 112:471–476

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Indolfi G, Bartolini E, Olivito B, Azzari C, Resti M (2012) Autoimmunity and extrahepatic manifestations in treatment-naïve children with chronic hepatitis C virus infection. Clin Dev Immunol. doi:10.1155/2012/785627. Epub 2012 May 8

    PubMed Central  PubMed  Google Scholar 

  16. Jonas MM (2002) Children with hepatitis C. Hepatology 36(5 Suppl 1):S173–S178

    Article  PubMed  Google Scholar 

  17. Kelly D, Skidmore S (2002) Hepatitis C-Z: recent advances. Arch Dis Child 86:339–343

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Lenzi M, Bellentani S, Saccoccio G, Muratori P, Masutti F, Muratori L, Cassani F, Bianchi FB, Tiribelli C (1999) Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case–control study of the Dionysos cohort. Gut 45:435–441

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, Grippon P, Hoang C, Valla D, Piette JC (1994) Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 106:1291–1300

    CAS  PubMed  Google Scholar 

  20. Mast EE, Hwang LY, Seto DS, Nolte FS, Nainan OV, Wurtzel H, Alter MJ (2005) Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis 192:1880–1889

    Article  PubMed  Google Scholar 

  21. Minola E, Prati D, Suter F, Maggiolo F, Caprioli F, Sonzogni A, Fraquelli M, Paggi S, Conte D (2002) Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C. Blood 99:4588–4591

    Article  CAS  PubMed  Google Scholar 

  22. Muratori P, Muratori L, Verucchi G, Attard L, Bianchi FB, Lenzi M (2003) Non-organ-specific autoantibodies in children with chronic hepatitis C: clinical significance and impact on interferon treatment. Clin Infect Dis 37:1320–1326

    Article  PubMed  Google Scholar 

  23. Pembrey L, Newell M-L, Tovo P-A (2005) The management of HCV infected pregnant women and their children European paediatric HCV network. J Hepatol 43:515–525

    Article  PubMed  Google Scholar 

  24. Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J (2001) Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 34:730–739

    Article  CAS  PubMed  Google Scholar 

  25. Resti M, Jara P, Hierro L, Azzari C, Giacchino R, Zuin G, Zancan L, Pedditzi S, Bortolotti F (2003) Clinical features and progression of perinatally acquired hepatitis C virus infection. J Med Virol 70:373–377

    Article  PubMed  Google Scholar 

  26. Rumbo C, Fawaz RL, Emre SH, Suchy FJ, Kerkar N, Morotti RA, Shneider BL (2006) Hepatitis C in children: a quaternary referral center perspective. J Pediatr Gastroenterol Nutr 43:209–216

    Article  PubMed  Google Scholar 

  27. Ryder SD, Irving WL, Jones DA, Neal KR, Underwood JC (2004) Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study. Gut 53:451–455

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Seeff LB (2002) Natural history of chronic hepatitis C. Hepatology 36(5 Suppl 1):S35–S46

    Article  PubMed  Google Scholar 

  29. Stroffolini T, Colloredo G, Gaeta GB, Sonzogni A, Angeletti S, Marignani M, Pasquale G, Venezia G, Craxì A, Almasio P (2004) Does an «autoimmune» profile affect the clinical profile of chronic hepatitis C? An Italian multicentre survey. J Viral Hepat 11:257–262

    Article  CAS  PubMed  Google Scholar 

  30. Sugden PB, Cameron B, Bull R, White PA, Lloyd AR (2012) Occult infection with hepatitis C virus: friend or foe? Immunol Cell Biol 90:763–773

    Article  CAS  PubMed  Google Scholar 

  31. Tovo P-A, Lazier L, Versace A (2005) Hepatitis B virus and hepatitis C virus infections in children. Curr Opin Infect Dis 18:261–266

    Article  PubMed  Google Scholar 

  32. Vogt M, Lang T, Frösner G, Klingler C, Sendl AF, Zeller A, Wiebecke B, Langer B, Meisner H, Hess J (1999) Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med 341:866–870

    Article  CAS  PubMed  Google Scholar 

  33. Williams MJ, Lawson A, Neal KR, Ryder SD, Irving WL (2009) Autoantibodies in chronic hepatitis C virus infection and their association with disease profile. J Viral Hepat 16:325–331

    Article  CAS  PubMed  Google Scholar 

  34. Wong VS, Egner W, Elsey T, Brown D, Alexander GJ (1996) Incidence, character and clinical relevance of mixed cryoglobulinaemia in patients with chronic hepatitis C virus infection. Clin Exp Immunol 104:25–31

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  35. World Health Organization (2002) Hepatitis C. Available at: http://www.who.int/csr/disease/hepatitis/Hepc.pdf. Accessed 07 Jan 2014.

  36. Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB (2007) Extrahepatic manifestations of hepatitis C virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis 39:2–17

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors have no conflicts of interest to declare and no financial supports to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Silvia Garazzino.

Additional information

Communicated by David Nadal

Rights and permissions

Reprints and permissions

About this article

Cite this article

Garazzino, S., Calitri, C., Versace, A. et al. Natural history of vertically acquired HCV infection and associated autoimmune phenomena. Eur J Pediatr 173, 1025–1031 (2014). https://doi.org/10.1007/s00431-014-2286-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-014-2286-6

Keywords

Navigation